Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: Results of two randomized double blind controlled multiinstitutional trials

Aman U. Buzdar, Robert Smith, Charles Vogel, Philip Bonomi, Alan M. Keller, Gregory Favis, Mary Mulagha, Judy Cooper

Research output: Contribution to journalArticlepeer-review

104 Scopus citations

Fingerprint

Dive into the research topics of 'Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: Results of two randomized double blind controlled multiinstitutional trials'. Together they form a unique fingerprint.

Medicine & Life Sciences